CAS: 545-80-2; (1,1-Dimethylpyrrolidin-1-Ium-2-yl)Methyl 2-Hydroxy-2,2-Diphenylacetate,Methyl Sulfate
该化合物是一种四硝基铵抗胆碱酯剂,主要用于胃肠胃和生殖器紊乱的抗呼吸系统性能,在肌肉癌胆碱酯酶受体中起着竞争对手的作用,减少了肌肉的肌肉萎缩和隐秘活动,甲基硫酸盐的配方提高了溶性性和生物利用率,确保了一致的药理效应.它的四硝基硫酸盐结构限制了...
- ⚠️《化妆品禁用原料目录》
- 英文名称(1,1-Dimethylpyrrolidin-1-Ium-2-yl)Methyl 2-Hydroxy-2,2-Diphenylacetate,Methyl Sulfate
- 中文名称甲硫泊尔定
- IUPAC名称2-((2-hydroxy-2,2-diphenylacetoxy)methyl)-1,1-dimethylpyrrolidin-1-ium methyl sulfate
- CAS编号545-80-2
- MFCD编号:MFCD00865161
- EINECS号:208-894-6
- FDA UNII编号:564C0W9848
- 分子式:C21H26NO3.CH3O4S分子量:451.537
- 产品CID: 2514828
- 产品分类有机原料 → 有机酸及其衍生物 → 有机硫酸及其衍生物
MSDS等安全信息
合成工艺路线路线简述
海关参考信息
- 2902600000-乙苯
2905121000-正丙醇
2905130000-正丁醇
2905310000-1,2-乙二醇 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2014315720-A1
优先权日:2012-10-24
标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
发明人：FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
权利人:CELANESE ACETATE LLC
摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
主要参考文献
1: Hainer V, Zák A, Bakos K, Wernischová V, Bĕlikovová H. Vliv cholinergní blokády Nactonem na sekreci inzulínu u obézních pacientů [Nacton-induced cholinergic block and its effect on insulin secretion in obese patients]. Cas Lek Cesk. 1982 Jul;121(27):844-7. Czech.
66:15-26.
65:583-90. Portuguese.
合成参考文献
参考文献:10.1007/978-3-642-39546-8_34
摘要:Hougaard MG, Thyssen JP. Treatment of Hand Eczema Caused by Hyperhidrosis. 2014. In: Textbook of Hand Eczema. : Springer Berlin Heidelberg; 2014.
参考文献:10.2165/00042310-200420100-00006
摘要:&NA;. No sweat hyperhidrosis can be controlled. Drugs & Therapy Perspectives. 2004 Oct;20(10):17–20. doi: 10.2165/00042310-200420100-00006.
参考文献:10.1007/978-4-431-66908-1_13
摘要:Inaba M, Inaba Y. Pharmaceutical and Physical Treatment Procedures for Axillary Bromidrosis. 1992. In: Human Body Odor. : Springer Japan; 1992.
参考文献:10.1007/978-3-662-00181-3_30
摘要:Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK. Diseases of Eccrine Sweat Glands. 1991. In: Dermatology. : Springer Berlin Heidelberg; 1991.
📝 需求与反馈
尽可能描述清楚需求与问题信息
